Results
74,087 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $52K 541 sh | Sep 18, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $52K 541 sh | Sep 18, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $55K 586 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Ross Jessica PChief Financial Officer |  GTLBGitlab Inc.Tax withholding | F | $1.59M 32.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $107K 1,079 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $144K 1,470 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Mancini AnthonySee Remarks |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $348K 1,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Fortunato DavidDirector, CEO and President |  WLTHWEALTHFRONT CORPOpen-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Ridloff ElenaCFO and CBO |  SIONSionna Therapeutics, Inc.Grant or award | A | — 47.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Ridloff ElenaCFO and CBO | SIONSionna Therapeutics, Inc. Grant or award | A | — 47.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Kodialam Rajini SundarDirector |  STUBStubHub Holdings, Inc.Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Lumpkin AlexandraChief Legal Officer |  REAXReal REMAX Group Inc.Option exercise | M | — 302 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Fuchs ThomasDirector | WGSGeneDx Holdings Corp. Option exercise | M | — 1,146 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Blackburn Jeffrey MDirector | STUBStubHub Holdings, Inc. Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Epperly Melissa B,Director |  ROIVRoivant Sciences Ltd.Grant or award | A | — 5,054 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Patterson ThomasDirector, 10% Owner | STUBStubHub Holdings, Inc. Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | McKee CharlotteCMO and Head of R&D | SIONSionna Therapeutics, Inc. Grant or award | A | — 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $34K 800 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Stetter MarkDirector |  ZTSZoetis Inc.Grant or award | A | $25K 342 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | McKee CharlotteCMO and Head of R&D | SIONSionna Therapeutics, Inc. Grant or award | A | — 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 20 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $155K 1,020 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Guerrier AlixDirector |  SCHLSCHOLASTIC CORPGrant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $770K 25.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Li LindaDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Walker VerdellDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Kleiser Kirk E.Director |  CLSTCatalyst Bancorp, Inc.Option exercise | M | $225K 16.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Dumont Robert LouisDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Henderson KayaDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Cislini JeffSVP & General Counsel | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $319K 10.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 19 | Baer MattDirector, Chief Executive Officer |  SFIXStitch Fix, Inc.Tax withholding | F | $338K 115.1K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 12.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 19 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Derivative conversion | C | $1.53M 17.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $4,961 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 18 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $3.01M 107.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Rozenblat JennaPresident | REAXReal REMAX Group Inc. Disposition to issuer | D | — 333 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 18.8K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Furner John R.Director, President & CEO |  WMTWalmart Inc.Open-market sale · 10b5-1 plan | SELL | $754K 7,080 sh | Sep 18, 2026 traded Sep 17, 2026 |